These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8415579)
1. Making tissue-type plasminogen activator more fibrin specific. Paoni NF; Chow AM; Peña LC; Keyt BA; Zoller MJ; Bennett WF Protein Eng; 1993 Jul; 6(5):529-34. PubMed ID: 8415579 [TBL] [Abstract][Full Text] [Related]
2. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator. Bakker AH; Nieuwenbroek NM; Verheijen JH Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642 [TBL] [Abstract][Full Text] [Related]
3. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator. Bakker AH; Rehberg EF; Marotti KR; Verheijen JH Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691 [TBL] [Abstract][Full Text] [Related]
4. Involvement of residues 296-299 in the enzymatic activity of tissue-type plasminogen activator. Paoni NF; Refino CJ; Brady K; Peña LC; Nguyen HV; Kerr EM; Johnson AC; Wurm FM; van Reis R; Botstein D Protein Eng; 1992 Apr; 5(3):259-66. PubMed ID: 1409547 [TBL] [Abstract][Full Text] [Related]
5. A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators. Eastman D; Wurm FM; van Reis R; Higgins DL Biochemistry; 1992 Jan; 31(2):419-22. PubMed ID: 1731899 [TBL] [Abstract][Full Text] [Related]
6. Variants of human tissue-type plasminogen activator substituted at the protease cleavage site and glycosylation sites, and truncated at the N- and C-termini. Haigwood NL; Mullenbach GT; Moore GK; DesJardin LE; Tabrizi A; Brown-Shimer SL; Stauss H; Stöhr HA; Pâques EP Protein Eng; 1989 Aug; 2(8):611-20. PubMed ID: 2510149 [TBL] [Abstract][Full Text] [Related]
7. Variants of tissue-type plasminogen activator with substantially enhanced response and selectivity toward fibrin co-factors. Strandberg L; Madison EL J Biol Chem; 1995 Oct; 270(40):23444-9. PubMed ID: 7559505 [TBL] [Abstract][Full Text] [Related]
8. Studies on the localization and accessibility of sites in fibrin which are involved in the acceleration of the activation of plasminogen by tissue-type plasminogen activator. Nieuwenhuizen W; Schielen WJ; Yonekawa O; Tesser GI; Voskuilen M Adv Exp Med Biol; 1990; 281():83-91. PubMed ID: 2129380 [No Abstract] [Full Text] [Related]
9. Structural features mediating fibrin selectivity of vampire bat plasminogen activators. Bringmann P; Gruber D; Liese A; Toschi L; Krätzchmar J; Schleuning WD; Donner P J Biol Chem; 1995 Oct; 270(43):25596-603. PubMed ID: 7592732 [TBL] [Abstract][Full Text] [Related]
10. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis. Weening-Verhoeff EJ; Quax PH; van Leeuwen RT; Rehberg EF; Marotti KR; Verheijen JH Protein Eng; 1990 Dec; 4(2):191-8. PubMed ID: 1963688 [TBL] [Abstract][Full Text] [Related]
11. Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator. Stewart RJ; Fredenburgh JC; Leslie BA; Keyt BA; Rischke JA; Weitz JI J Biol Chem; 2000 Apr; 275(14):10112-20. PubMed ID: 10744692 [TBL] [Abstract][Full Text] [Related]
12. Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain. Ikenaka Y; Yajima K; Yahara H; Maruyama H; Matsumoto K; Okada K; Ueshima S; Matsuo O Blood Coagul Fibrinolysis; 1992 Aug; 3(4):381-7. PubMed ID: 1330023 [TBL] [Abstract][Full Text] [Related]
13. High resolution analysis of functional determinants on human tissue-type plasminogen activator. Bennett WF; Paoni NF; Keyt BA; Botstein D; Jones AJ; Presta L; Wurm FM; Zoller MJ J Biol Chem; 1991 Mar; 266(8):5191-201. PubMed ID: 1900516 [TBL] [Abstract][Full Text] [Related]
14. Locating the unpaired cysteine of tissue-type plasminogen activator. Sehl LC; Nguyen HV; Berleau LT; Arcila P; Bennett WF; Keyt BA Protein Eng; 1996 Mar; 9(3):283-90. PubMed ID: 8736495 [TBL] [Abstract][Full Text] [Related]
15. Identification of a hydrophobic exosite on tissue type plasminogen activator that modulates specificity for plasminogen. Ke SH; Tachias K; Lamba D; Bode W; Madison EL J Biol Chem; 1997 Jan; 272(3):1811-6. PubMed ID: 8999865 [TBL] [Abstract][Full Text] [Related]
16. Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerisation. Nieuwenhuizen W Thromb Res; 1994 Aug; 75(3):343-7. PubMed ID: 7992246 [TBL] [Abstract][Full Text] [Related]
17. Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain. Hinzmann B; Wernicke D; Pfeifer M; Zacharias U; Fischer B; Eisenmenger F; Will H Eur J Biochem; 1993 Apr; 213(1):437-43. PubMed ID: 8386628 [TBL] [Abstract][Full Text] [Related]
18. The effect of the one-chain to two-chain conversion in tissue plasminogen activator: characterization of mutations at position 275. Higgins DL; Lamb MC; Young SL; Powers DB; Anderson S Thromb Res; 1990 Feb; 57(4):527-39. PubMed ID: 2139248 [TBL] [Abstract][Full Text] [Related]